Does MIRABEGRON Cause Interstitial lung disease? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Interstitial lung disease have been filed in association with MIRABEGRON (MIRABEGRON). This represents 0.1% of all adverse event reports for MIRABEGRON.
14
Reports of Interstitial lung disease with MIRABEGRON
0.1%
of all MIRABEGRON reports
3
Deaths
5
Hospitalizations
How Dangerous Is Interstitial lung disease From MIRABEGRON?
Of the 14 reports, 3 (21.4%) resulted in death, 5 (35.7%) required hospitalization, and 1 (7.1%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MIRABEGRON. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does MIRABEGRON Cause?
Drug ineffective (4,151)
Off label use (1,704)
Intentional product misuse (1,416)
Dizziness (1,297)
Headache (1,288)
Blood pressure increased (1,100)
Hypertension (1,057)
Dry mouth (1,034)
Diarrhoea (921)
Pain (921)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which MIRABEGRON Alternatives Have Lower Interstitial lung disease Risk?
MIRABEGRON vs MIRALAX
MIRABEGRON vs MIRCERA
MIRABEGRON vs MIRENA
MIRABEGRON vs MIRIKIZUMAB-MRKZ
MIRABEGRON vs MIRTAZAPINE